Effects of intensive glucose lowering in type 2 diabetes

Hertzel C. Gerstein, Michael E. Miller, Robert P. Byington, David C. Goff, J. Thomas Bigger, John B. Buse, William C. Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H. Grimm, Jeffrey L. Probstfield, Denise G. Simons-Morton, William T. Friedewald, A. M. Gotto, K. Bailey, D. Gohdes, S. Haffner, R. Hiss, K. Jamerson, K. LeeD. Nathan, J. Sowers, L. Walters, W. T. Friedewald, J. B. Buse, J. T. Bigger, R. P. Byington, W. C. Cushman, H. C. Gerstein, H. N. Ginsberg, D. C. Goff, J. L. Probstfield, D. G. Simons-Morton, H. C. Gerstein, S. Yusuf, Z. Punthakee, R. Russo, S. Anand, B. Cracknell, T. Cukierman-Yaffe, A. Gafni, G. Guyatt, S. Hall, J. Kaszyca, E. Lonn, E. R. Seaquist, J. B. Redmon, K. Peterson, J. L. Feldman, T. J. Mendenhall, The Action to Control Cardiovascular Risk in Diabetes Study Group

Research output: Contribution to journalArticlepeer-review

6413 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of intensive glucose lowering in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences